GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
09:39 Aug 28, 2009 |
English language (monolingual) [PRO] Medical - Medical: Pharmaceuticals | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Rolf Keiser Switzerland Local time: 13:19 | ||||||
Grading comment
|
SUMMARY OF ALL EXPLANATIONS PROVIDED | ||||
---|---|---|---|---|
3 +1 | vde. below |
|
Summary of reference entries provided | |||
---|---|---|---|
This report shows the details |
|
vde. below Explanation: according to my understanding escalation could mean the increase of the individual dosage while expansion could imply extending the dosage to a greater number of subjects (e.g. test patients) -------------------------------------------------- Note added at 30 days (2009-09-28 08:34:04 GMT) Post-grading -------------------------------------------------- Thanks, jmarcin2 |
| |
Grading comment
| ||
Login to enter a peer comment (or grade) |
4 hrs |
Reference: This report shows the details Reference information: Pls. refer to the study protocoll for both phases, dose escalation and dose expansion. http://download.veritasmedicine.com/REGFILES/amgen/08D_FDAMA... The point is that in the second phase additional 10 subjects (in this study example) will receive the highest dose (at completion of dose escalation phase) and stay on that dose. HTH -------------------------------------------------- Note added at 4 hrs (2009-08-28 13:42:54 GMT) -------------------------------------------------- sorry: *protocol* (not protocoll) |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.